Skip to main content
Top
Published in: Digestive Diseases and Sciences 7/2013

01-07-2013 | Original Article

Barrett’s Metaplasia and Colonic Neoplasms: A Significant Association in a 203,534-Patient Study

Authors: Amnon Sonnenberg, Robert M. Genta

Published in: Digestive Diseases and Sciences | Issue 7/2013

Login to get access

Abstract

Background and Aim

The presence of an association between Barrett’s metaplasia and colonic neoplasia has remained controversial. The aim of the study was to test the presence of this association, using a large national database.

Methods

From a computerized database of surgical pathology reports, we selected 203,000 subjects who underwent colonoscopy and esophago-gastro-duodenoscopy with biopsy results available from both procedures. In a case–control study we compared the occurrence of Barrett’s metaplasia in patients with and without various types of colonic neoplasms.

Results

Barrett’s metaplasia occurred more frequently among patients with hyperplastic polyps (OR = 2.14, 95 % CI 2.02–2.27), adenomatous polyps (2.52, 2.41–2.64), advanced adenomas (2.10, 1.90–2.32), villous adenomas or adenomas with high-grade (HG) dysplasia (2.45, 2.28–2.64), and colonic adenocarcinomas (1.75, 1.39–2.22). The association between Barrett’s metaplasia and colonic neoplasm applied similarly to polyps of different size, number and location within the large bowel. These types of association could also be confirmed when analyzed separately for Barrett’s metaplasia characterized by low-grade or HG dysplasia, as well as esophageal adenocarcinoma.

Conclusions

The data support the existence of a true association between Barrett’s metaplasia and various types of colonic neoplasm. The association may be more interesting for its potential insights into the pathogenesis of the two disorders than its actual clinical implications.
Literature
1.
go back to reference Sontag SJ, Schnell TG, Chejfec G, et al. Barrett’s oesophagus and colonic tumours. Lancet. 1985;1:946–949.PubMedCrossRef Sontag SJ, Schnell TG, Chejfec G, et al. Barrett’s oesophagus and colonic tumours. Lancet. 1985;1:946–949.PubMedCrossRef
2.
go back to reference Howden CW, Hornung CA. A systematic review of the association between Barrett’s esophagus and colon neoplasms. Am J Gastroenterol. 1995;90:1814–1819.PubMed Howden CW, Hornung CA. A systematic review of the association between Barrett’s esophagus and colon neoplasms. Am J Gastroenterol. 1995;90:1814–1819.PubMed
3.
go back to reference Siersema PD, Yu S, Sahbaie P, et al. Colorectal neoplasia in veterans is associated with Barrett’s esophagus but not with proton-pump inhibitor or aspirin/NSAID use. Gastrointest Endosc. 2006;63:581–586.PubMedCrossRef Siersema PD, Yu S, Sahbaie P, et al. Colorectal neoplasia in veterans is associated with Barrett’s esophagus but not with proton-pump inhibitor or aspirin/NSAID use. Gastrointest Endosc. 2006;63:581–586.PubMedCrossRef
4.
go back to reference Bollschweiler E, Schloesser T, Leers J, Vallböhmer D, Schäfer H, Hölscher AH. High prevalence of colonic polyps in white males with esophageal adenocarcinoma. Dis Colon Rectum. 2009;52:299–304.PubMedCrossRef Bollschweiler E, Schloesser T, Leers J, Vallböhmer D, Schäfer H, Hölscher AH. High prevalence of colonic polyps in white males with esophageal adenocarcinoma. Dis Colon Rectum. 2009;52:299–304.PubMedCrossRef
5.
go back to reference de Jonge PJ, van Blankenstein M, Looman CW, Casparie MK, Meijer GA, Kuipers EJ. Risk of colorectal cancer in patients with Barrett’s esophagus: a Dutch population-based study. Am J Gastroenterol. 2010;105:77–83.PubMedCrossRef de Jonge PJ, van Blankenstein M, Looman CW, Casparie MK, Meijer GA, Kuipers EJ. Risk of colorectal cancer in patients with Barrett’s esophagus: a Dutch population-based study. Am J Gastroenterol. 2010;105:77–83.PubMedCrossRef
6.
go back to reference Poorman JC, Lieberman DA, Ippoliti AF, Weber LJ, Weinstein WM. The prevalence of colonic neoplasia in patients with Barrett’s esophagus: prospective assessment in patients 50–80 years old. Am J Gastroenterol. 1997;92:592–596.PubMed Poorman JC, Lieberman DA, Ippoliti AF, Weber LJ, Weinstein WM. The prevalence of colonic neoplasia in patients with Barrett’s esophagus: prospective assessment in patients 50–80 years old. Am J Gastroenterol. 1997;92:592–596.PubMed
7.
go back to reference Laitakari R, Laippala P, Isolauri J. Barrett’s oesophagus is not a risk factor for colonic neoplasia: a case–control study. Ann Med. 1995;27:499–502.PubMedCrossRef Laitakari R, Laippala P, Isolauri J. Barrett’s oesophagus is not a risk factor for colonic neoplasia: a case–control study. Ann Med. 1995;27:499–502.PubMedCrossRef
8.
go back to reference Lagergren J, Nyren O. No association between colon cancer and adenocarcinoma of the oesophagus in a population based cohort study in Sweden. Gut. 1999;44:819–821.PubMedCrossRef Lagergren J, Nyren O. No association between colon cancer and adenocarcinoma of the oesophagus in a population based cohort study in Sweden. Gut. 1999;44:819–821.PubMedCrossRef
9.
go back to reference Murphy SJ, Anderson LA, Mainie I, et al. Incidence of colorectal cancer in a population-based cohort of patients with Barrett’s oesophagus. Scand J Gastroenterol. 2005;40:1449–1453 (erratum in: Scand J Gastroenterol. 2006;41:247). Murphy SJ, Anderson LA, Mainie I, et al. Incidence of colorectal cancer in a population-based cohort of patients with Barrett’s oesophagus. Scand J Gastroenterol. 2005;40:1449–1453 (erratum in: Scand J Gastroenterol. 2006;41:247).
10.
go back to reference Solaymani-Dodaran M, Logan RF, West J, Card T, Coupland C. Risk of extra-oesophageal malignancies and colorectal cancer in Barrett’s oesophagus and gastro-oesophageal reflux. Scand J Gastroenterol. 2004;39:680–685.PubMedCrossRef Solaymani-Dodaran M, Logan RF, West J, Card T, Coupland C. Risk of extra-oesophageal malignancies and colorectal cancer in Barrett’s oesophagus and gastro-oesophageal reflux. Scand J Gastroenterol. 2004;39:680–685.PubMedCrossRef
11.
go back to reference Schouten LJ, Steevens J, Huysentruyt CJ, et al. Total cancer incidence and overall mortality are not increased among patients with Barrett’s esophagus. Clin Gastroenterol Hepatol. 2011;9:754–761.PubMedCrossRef Schouten LJ, Steevens J, Huysentruyt CJ, et al. Total cancer incidence and overall mortality are not increased among patients with Barrett’s esophagus. Clin Gastroenterol Hepatol. 2011;9:754–761.PubMedCrossRef
12.
go back to reference Cook MB, Wild CP, Everett SM, et al. Risk of mortality and cancer incidence in Barrett’s esophagus. Cancer Epidemiol Biomarkers Prev. 2007;16:2090–2096.PubMedCrossRef Cook MB, Wild CP, Everett SM, et al. Risk of mortality and cancer incidence in Barrett’s esophagus. Cancer Epidemiol Biomarkers Prev. 2007;16:2090–2096.PubMedCrossRef
13.
go back to reference Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–1181.PubMedCrossRef Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–1181.PubMedCrossRef
14.
go back to reference Srivastava A, Odze RD, Lauwers GY, Redston M, Antonioli DA, Glickman JN. Morphologic features are useful in distinguishing Barrett esophagus from carditis with intestinal metaplasia. Am J Surg Pathol. 2007;31:1733–1741.PubMedCrossRef Srivastava A, Odze RD, Lauwers GY, Redston M, Antonioli DA, Glickman JN. Morphologic features are useful in distinguishing Barrett esophagus from carditis with intestinal metaplasia. Am J Surg Pathol. 2007;31:1733–1741.PubMedCrossRef
15.
go back to reference Winawer SJ, Zauber AG. The advanced adenoma as the primary target of screening. Gastrointest Endosc Clin N Am. 2002;12:1–9.PubMedCrossRef Winawer SJ, Zauber AG. The advanced adenoma as the primary target of screening. Gastrointest Endosc Clin N Am. 2002;12:1–9.PubMedCrossRef
16.
go back to reference Sonnenberg A, Amorosi LS, Lacey MJ, Lieberman DA. Patterns of endoscopy in the United States: analysis of data from the Centers for Medicare and Medicaid Services and the National Endoscopic Database. Gastrointest Endosc. 2008;67:489–496.PubMedCrossRef Sonnenberg A, Amorosi LS, Lacey MJ, Lieberman DA. Patterns of endoscopy in the United States: analysis of data from the Centers for Medicare and Medicaid Services and the National Endoscopic Database. Gastrointest Endosc. 2008;67:489–496.PubMedCrossRef
17.
go back to reference Sontag S. The Colono–Barrett relationship: a tie that will not die. Gastrointest Endosc. 2006;63:587–589.PubMedCrossRef Sontag S. The Colono–Barrett relationship: a tie that will not die. Gastrointest Endosc. 2006;63:587–589.PubMedCrossRef
18.
go back to reference Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni JF Jr. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control. 2006;17:901–909.PubMedCrossRef Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni JF Jr. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control. 2006;17:901–909.PubMedCrossRef
19.
go back to reference Corley DA, Kubo A, Levin TR, et al. Abdominal obesity and body mass index as risk factors for Barrett’s esophagus. Gastroenterology. 2007;133:34–41.PubMedCrossRef Corley DA, Kubo A, Levin TR, et al. Abdominal obesity and body mass index as risk factors for Barrett’s esophagus. Gastroenterology. 2007;133:34–41.PubMedCrossRef
20.
go back to reference Lagergren J. Influence of obesity on the risk of esophageal disorders. Nat Rev Gastroenterol Hepatol. 2011;8:340–347.PubMedCrossRef Lagergren J. Influence of obesity on the risk of esophageal disorders. Nat Rev Gastroenterol Hepatol. 2011;8:340–347.PubMedCrossRef
21.
go back to reference Bernstein H, Bernstein C, Payne CM, Dvorak K. Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gastroenterol. 2009;15:3329–3340.PubMedCrossRef Bernstein H, Bernstein C, Payne CM, Dvorak K. Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gastroenterol. 2009;15:3329–3340.PubMedCrossRef
22.
go back to reference McQuaid KR, Laine L, Fennerty MB, Souza R, Spechler SJ. Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia. Aliment Pharmacol Ther. 2011;34:146–165.PubMedCrossRef McQuaid KR, Laine L, Fennerty MB, Souza R, Spechler SJ. Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia. Aliment Pharmacol Ther. 2011;34:146–165.PubMedCrossRef
23.
go back to reference Thorburn CM, Friedman GD, Dickinson CJ, Vogelman JH, Orentreich N, Parsonnet J. Gastrin and colorectal cancer: a prospective study. Gastroenterology. 1998;115:275–280.PubMedCrossRef Thorburn CM, Friedman GD, Dickinson CJ, Vogelman JH, Orentreich N, Parsonnet J. Gastrin and colorectal cancer: a prospective study. Gastroenterology. 1998;115:275–280.PubMedCrossRef
24.
25.
go back to reference Trivers KF, Sabatino SA, Stewart SL. Trends in esophageal cancer incidence by histology, United States, 1998–2003. Int J Cancer. 2008;123:1422–1428.PubMedCrossRef Trivers KF, Sabatino SA, Stewart SL. Trends in esophageal cancer incidence by histology, United States, 1998–2003. Int J Cancer. 2008;123:1422–1428.PubMedCrossRef
26.
go back to reference American Gastroenterological Association, Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140:1084–1091.PubMedCrossRef American Gastroenterological Association, Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140:1084–1091.PubMedCrossRef
27.
go back to reference Wani S, Falk G, Hall M, et al. Patients with nondysplastic Barrett’s esophagus have low risks for developing dysplasia or esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2011;9:220–227.PubMedCrossRef Wani S, Falk G, Hall M, et al. Patients with nondysplastic Barrett’s esophagus have low risks for developing dysplasia or esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2011;9:220–227.PubMedCrossRef
28.
go back to reference Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570–1595.PubMedCrossRef Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570–1595.PubMedCrossRef
Metadata
Title
Barrett’s Metaplasia and Colonic Neoplasms: A Significant Association in a 203,534-Patient Study
Authors
Amnon Sonnenberg
Robert M. Genta
Publication date
01-07-2013
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 7/2013
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-013-2565-5

Other articles of this Issue 7/2013

Digestive Diseases and Sciences 7/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.